PharmacovigilanceOfficial
CMS issues proposed rule on 2028 Medicare Advantage and Part D changes
🇺🇸 CMS · Fri 20 Nov 2026
The US agency has published CMS-4214-P2, proposing policy and technical changes across Medicare Advantage, Part D and Cost Plan programmes for contract year 2028.
The US Centers for Medicare & Medicaid Services (CMS) has issued a proposed rule, designated CMS-4214-P2, covering policy and technical changes for contract year 2028. The rule applies to the Medicare Advantage programme, the Medicare Prescription Drug Benefit Program (Part D) and the Medicare Cost Plan programme.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Article written by VigiEye from the official source (CMS). AI-assisted; check the source before acting.
More Pharmacovigilance
All →
FDA early alert: Heraeus Medevio recalls vascular guidewires over hydrophilic coating clumping risk
🇺🇸 FDA MedWatch · Fri 20 Nov 2026
EMA publishes PSUSA outcome for ibuprofen medicines, concluding with a variation
🇪🇺 EMA · Fri 20 Nov 2026
EMA publishes PSUSA outcome for nationally authorised split-virion inactivated influenza vaccines, recommending a variation
🇪🇺 EMA · Fri 20 Nov 2026
CMS proposes Medicare Advantage rule to ease market entry and widen beneficiary choice
🇺🇸 CMS · Fri 20 Nov 2026
FDA warns Florida clinical investigator over consent failings in INSTI HIV self-test study
🇺🇸 FDA CBER · Fri 20 Nov 2026
Breckenridge recalls one lot of propranolol ER 60 mg capsules over possible metal contamination
🇺🇸 FDA MedWatch · Fri 20 Nov 2026